2017
DOI: 10.1111/bph.13887
|View full text |Cite
|
Sign up to set email alerts
|

Single and combined effects of Δ9‐tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy‐induced neuropathic pain

Abstract: CBD may be potent and effective at preventing the development of chemotherapy-induced peripheral neuropathy, and its clinical use may be enhanced by co-administration of low doses of THC. These treatment strategies would increase the therapeutic window of cannabis-based pharmacotherapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
114
1
3

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 140 publications
(122 citation statements)
references
References 39 publications
4
114
1
3
Order By: Relevance
“…Therefore, it is also critical to determine the efficacy of CBD alone compared with THC and the CBD + THC combination, to determine optimal cannabinoid‐based treatment strategies for the future. Recently, we have demonstrated, for example, that while both CBD and THC alone prevent development of mechanical sensitivity in a mouse model of chemotherapy‐induced peripheral neuropathic pain, a 1:1 ratio of CBD to THC acted synergistically, leading to an approximate 10‐fold increase in potency in the model (King et al, ). Thus, CBD as a monotherapy may represent a safe and effective treatment strategy for neuropathic pain, while co‐administration of equivalent THC + CBD doses may lead to lower doses of each agent being necessary, thereby attaining the goal of decreasing THC‐associated adverse effects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, it is also critical to determine the efficacy of CBD alone compared with THC and the CBD + THC combination, to determine optimal cannabinoid‐based treatment strategies for the future. Recently, we have demonstrated, for example, that while both CBD and THC alone prevent development of mechanical sensitivity in a mouse model of chemotherapy‐induced peripheral neuropathic pain, a 1:1 ratio of CBD to THC acted synergistically, leading to an approximate 10‐fold increase in potency in the model (King et al, ). Thus, CBD as a monotherapy may represent a safe and effective treatment strategy for neuropathic pain, while co‐administration of equivalent THC + CBD doses may lead to lower doses of each agent being necessary, thereby attaining the goal of decreasing THC‐associated adverse effects.…”
Section: Discussionmentioning
confidence: 99%
“…For example, CBD may either synergize with or antagonize THC effects to enhance wanted actions and/or antagonize adverse actions (Russo, ). We have recently demonstrated, for example, that a 1:1 ratio of CBD to THC synergistically prevented development of mechanical sensitivity in a mouse model of chemotherapy‐induced neuropathic pain, greatly decreasing the dose of each drug required to produce efficacy (King et al, ). A continuation of quantitative research is required to determine the scope of these interactions, including how they affect the adverse effects of THC.…”
Section: Introductionmentioning
confidence: 99%
“…These effects are associated with side effects such as appetite alterations, nausea, diarrhea and other gastrointestinal alterations, sleepiness, weight changes, and fatigue, among others . It is known that THC augments the analgesic effects of CBD . On the other hand, CBD potentiates or reduces some effects induced by THC .…”
Section: Is Cannabidiol a New Hope For Drug‐resistant Epilepsy?mentioning
confidence: 99%
“…In addition to its clinical utility, oxaliplatin is also used in pharmacological laboratories to induce a rodent model of CIPN‐related neuropathic pain that could be utilized in the search for novel therapies for CIPN prevention (Ohsawa et al., ) and treatment (Andoh, Kitamura, & Kuraishi, ; Deuis et al., ; Jiang et al., ; Kim et al., ; King et al., ; Pańczyk et al., ; K. Sałat et al., , ; Sałat & Sałat, ; Yoon, Lee, Roh, & Oh, ). To assess the effect of oxaliplatin on tactile allodynia, researchers worldwide take advantage of using von Frey filaments as an easy‐to‐use method.…”
Section: Introductionmentioning
confidence: 99%